HALAVEN 0,44 mg/ml, solution injectable

Business Listing - September 04, 2021

HALAVEN 0,44 mg/ml, solution injectable

HALAVEN 0,44 mg/ml, solution injectable solution injectable intraveineuse Autorisation active Procédure centralisée Commercialisée 3/17/2011 EISAI (ROYAUME-UNI)

Tags & Categories

intraveineuse active solution injectable autorisation procédure commercialisée centralisée eisai halaven

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business